Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma

L M Mittlmeier; M Unterrainer; A Todica; D A Clevert; C C Cyran; E Schmoeckel; S Rodler; P Bartenstein; C G Stief; H Ilhan; M Staehler

doi:10.1016/j.urology.2020.02.025

Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma

Urology. 2020 Jun:140:e10-e11. doi: 10.1016/j.urology.2020.02.025. Epub 2020 Apr 5.

Authors

L M Mittlmeier¹, M Unterrainer², A Todica², D A Clevert³, C C Cyran³, E Schmoeckel⁴, S Rodler⁵, P Bartenstein², C G Stief⁵, H Ilhan², M Staehler⁶

Affiliations

¹ Department of Urology, University Hospital, LMU Munich, Munich, Germany; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
² Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
³ Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
⁴ Institute of Pathology, University Hospital, LMU Munich, Munich, Germany.
⁵ Department of Urology, University Hospital, LMU Munich, Munich, Germany.
⁶ Department of Urology, University Hospital, LMU Munich, Munich, Germany. Electronic address: michael.staehler@med.uni-muenchen.de.

PMID: 32171695
DOI: 10.1016/j.urology.2020.02.025

Abstract

Metanephric adenoma (MA) describes a rare renal tumor and is generally considered a benign lesion. However, there are cases with regional lymphogenic and distant metastases. Noninvasive diagnosis of MA using conventional imaging remains challenging. Here, we describe a case of histologically verified MA with additional advanced molecular imaging consisting of ¹⁸F-PSMA-1007 PET/CT, ^99mTc-Sestamibi SPECT and contrast-enhanced ultrasound.

Publication types

Case Reports

MeSH terms

Adenoma / diagnostic imaging*
Aged
Female
Humans
Kidney Neoplasms / diagnostic imaging*
Molecular Imaging / methods